Neopharm Inactive 10-Q2003 Q0 Quarterly report

Filed: 14 Nov 02, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: accommodate, added, adverse, adversely, Ahmad, alerting, appointed, case, certify, certifying, Chancery, collectively, compel, complaint, compound, concluded, consolidated, Cooperative, corrective, covered, data, decision, defense, defined, disclosed, disclosure, disclsure, efficacy, enjoin, ensure, establishing, evaluated, evaluation, fact, formulation, fraud, gain, hearing, identified, II, Imran, inadequate, Institute, intellectual, internal, knowledge, lawsuit, lease, light, maintaining, matter, method, monetary, motion, moved, National, notice, omit, participation, prevent, prior, production, property, protection, realized, regulatory, relief, removed, requested, role, scheduled, SEC, Senior, shortened, side, significantly, space, specific, summarize, supervision, testing, therapeutic, thereon, uncertainty, unexpected, untrue, Upjohn, Vice

Removed: acceptance, Administration, approximate, check, competitive, continuing, dependence, electrostatic, Employer, file, Food, foreign, health, impact, issuer, key, listed, March, mark, number, par, past, personnel, preceding, pricing, shorter, stock, TRANSITION, Washington

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Neopharm similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 99.1

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18,

UNITED STATES CODE)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of Title 18, United States Code), each of the undersigned officers of NeoPharm, Inc., a Delaware corporation (the “Company”), does hereby certify with respect to the Quarterly Report of the Company on Form 10-Q for the quarter ended September 30, 2002 as filed with the Securities and Exchange Commission (the “10-Q Report”) that:

(1) the 10-Q Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the 10-Q Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 14, 2002	/s/ James M. Hussey
	James M. Hussey,
	Chief Executive Officer

Dated: November 14, 2002	/s/ Lawrence A. Kenyon
	Lawrence A. Kenyon,
	Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.